[The Ullrich-Turner syndrome].
The etiology of the Ullrich-Turner's syndrome is a chromosomal anomality, the karyotyp 45 XO being the most common one. This results in stunted growth, a number of deformities as pterygium colli or cubita valga, and primary amenorrhea due to gonadal dysgenesis. Treatment consists of anabolic steroids for improvement of growth and substitution of estrogens at a later age. Final height probably will rarely exceed 150 cm. Usually, patients are infertile.
D045930:Anabolic Agents / Q000627:therapeutic use; D002869:Chromosome Aberrations; D004392:Dwarfism / Q000209:etiology; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007006:Hypogonadism / Q000209:etiology; D007247:Infertility, Female / Q000209:etiology; D007621:Karyotyping; D011625:Pterygium / Q000601:surgery; D012730:Sex Chromosomes; D009626:Terminology as Topic; D014424:Turner Syndrome / Q000235:genetics* / Q000628:therapy
D045930:Anabolic Agents; D004967:Estrogens
Das Ullrich-Turner-Syndrom.